Editas Medicine, Inc.

EDIT - CIK 0001650664

Market cap-

Rank-

SEC filings693

EDIT income statement (quarterly)

The table below shows Editas Medicine, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Line item	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024
Revenue	$2.83M	$7.54M	$3.58M	$4.66M	$61.00K	$513.00K
Cost of revenue	-	-	-	-	-	-
Gross profit	-	-	-	-	-	-
R&D	$17.60M	$19.77M	$16.18M	$26.59M	$47.64M	$54.21M
SG&A

EDIT annual revenue (10-K history)

Editas Medicine, Inc. reported annual revenue of $40.52M for fiscal year 2025. That is up 25.4% from $32.31M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $6.05M (FY 2016) to $40.52M. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.